BioCryst Pharmaceuticals Inc. (BCRX) is priced at $10.80 after the most recent trading session. At the very opening of the session, the stock price was $10.45 and reached a high price of $10.9584, prior to closing the session it reached the value of $10.66. The stock touched a low price of $10.26.
Recently in News on February 18, 2021, BioCryst to Present at Upcoming Investor Conferences. BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the Cowen 41st Annual Healthcare Conference on Thursday, March 4, 2021 at 12:10 p.m. ET and the Barclays Annual Healthcare Conference on Thursday, March 11, 2021 at 8:00 a.m. ET. Both conferences are being held as virtual events. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
BioCryst Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.90 on 02/02/21, with the lowest value was $7.27 for the same time period, recorded on 01/05/21.
BioCryst Pharmaceuticals Inc. (BCRX) full year performance was 284.34%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BioCryst Pharmaceuticals Inc. shares are logging -16.28% during the 52-week period from high price, and 583.54% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.58 and $12.90.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6013035 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BioCryst Pharmaceuticals Inc. (BCRX) recorded performance in the market was 44.97%, having the revenues showcasing 142.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.83B, as it employees total of 140 workers.
BioCryst Pharmaceuticals Inc. (BCRX) in the eye of market guru’s
During the last month, 0 analysts gave the BioCryst Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.37, with a change in the price was noted +7.37. In a similar fashion, BioCryst Pharmaceuticals Inc. posted a movement of +214.87% for the period of last 100 days, recording 6,850,854 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BCRX is recording 2.26 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.80.
BioCryst Pharmaceuticals Inc. (BCRX): Stocks Technical analysis and Trends
Raw Stochastic average of BioCryst Pharmaceuticals Inc. in the period of last 50 days is set at 67.39%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 53.64%. In the last 20 days, the company’s Stochastic %K was 49.23% and its Stochastic %D was recorded 40.52%.
If we look into the earlier routines of BioCryst Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 44.97%. Additionally, trading for the stock in the period of the last six months notably improved by 139.47%, alongside a boost of 284.34% for the period of the last 12 months. The shares increased approximately by 13.09% in the 7-day charts and went down by 19.14% in the period of the last 30 days. Common stock shares were driven by 142.70% during last recorded quarter.